OptimizeRx (OPRX) Amortization of Deferred Charges (2010 - 2026)

OptimizeRx has disclosed Amortization of Deferred Charges across 5 years of filings, most recently posting $358000.0 for Q1 2026.

• Amortization of Deferred Charges for Q1 2026 came in at $358000.0, up 105.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (up 56.66% YoY), and the FY2025 annual result was $1.1 million, up 32.93% from the prior year.
• Amortization of Deferred Charges came in at $358000.0 for Q1 2026 at OptimizeRx, up from $325000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $437000.0 in Q2 2025 to a low of $174000.0 in Q1 2025.
• The 3-year median for Amortization of Deferred Charges is $182000.0 (2024), against an average of $255777.8.
• Peak annual rise in Amortization of Deferred Charges reached 140.11% in 2025, while the deepest fall reached 4.4% in 2025.
• OptimizeRx's Amortization of Deferred Charges stood at $288000.0 in 2024, then gained by 12.85% to $325000.0 in 2025, then advanced by 10.15% to $358000.0 in 2026.
• The last three Amortization of Deferred Charges figures came in at $358000.0 (Q1 2026), $325000.0 (Q4 2025), and $174000.0 (Q3 2025), per Business Quant data.